FindMyKOL
Clinical trialNCT00072579CompletedPhase 2Interventional

Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment

SponsorWake Forest University Health SciencesLeukemia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Colony-stimulating factors, such as sargramostim, may increase the number of immune cells found in bone marrow or peripheral blood and may bring about complete remission in patients who have chronic phase chronic myelogenous leukemia. PURPOSE: This phase II trial is studying sargramostim to see how well it works in treating patients with chronic phase chronic myelogenous leukemia that is not in complete cytogenetic remission after initial treatment.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ccop - Western Regional, Arizona

    Phoenix, Arizona, United States

  • Ccop - Bay Area Tumor Institute

    Oakland, California, United States

  • Ccop - Mount Sinai Medical Center

    Miami Beach, Florida, United States

  • Regional Radiation Oncology Center at Rome

    Rome, Georgia, United States

  • Ccop - Central Illinois

    Decatur, Illinois, United States

  • Kentuckiana Cancer Institute, Pllc

    Louisville, Kentucky, United States

  • Mbccop - Lsu Health Sciences Center

    New Orleans, Louisiana, United States

  • Alamance Cancer Center

    Burlington, North Carolina, United States

  • Hugh Chatham Memorial Hospital

    Elkin, North Carolina, United States

  • Southeastern Medical Oncology Center

    Goldsboro, North Carolina, United States

  • Brody School of Medicine at East Carolina University

    Greenville, North Carolina, United States

  • Comprehensive Cancer Center at Wake Forest University

    Winston-Salem, North Carolina, United States

  • Ccop - Columbus

    Columbus, Ohio, United States

  • Cancer Centers of the Carolinas - Eastside

    Greenville, South Carolina, United States

  • Ccop - Upstate Carolina

    Spartanburg, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Sargramostim →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2003
Primary completion
30 Apr 2006
Completion
31 Dec 2007
Last update posted
19 Jan 2017
Registered enrollment
—
Registry id
NCT00072579
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.